Attached files
file | filename |
---|---|
10-K - BIOMIMETIC THERAPEUTICS, INC. | v176821_10k.htm |
EX-32.2 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex32-2.htm |
EX-31.2 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex31-2.htm |
EX-32.1 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex32-1.htm |
EX-31.1 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex31-1.htm |
EX-21.1 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex21-1.htm |
EX-10.57 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex10-57.htm |
EX-10.56 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex10-56.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
We
consent to the incorporation by reference in the following Registration
Statements:
|
·
|
Registration
Statement (Form S-8 No. 333-135505) pertaining to the BioMimetic
Therapeutics, Inc. 2001 Long-Term Stock Incentive Plan and BioMimetic
Therapeutics, Inc. 2005 Employee Stock Purchase
Plan,
|
|
·
|
Registration
Statement (Form S-8 No. 333-157999) pertaining to the BioMimetic
Therapeutics, Inc. 401(k) Profit Sharing Plan &
Trust,
|
|
·
|
Registration
Statement (Form S-3 No. 333-160400) of BioMimetic Therapeutics, Inc.,
and
|
|
·
|
Registration
Statement (Form S-3 No. 333-160676) of BioMimetic Therapeutics,
Inc.;
|
of our
report dated March 12, 2010 with respect to the consolidated financial
statements of BioMimetic Therapeutics, Inc. and our report dated March 12, 2010
with respect to the effectiveness of internal control over financial reporting
of BioMimetic Therapeutics, Inc., included in this Annual Report (Form 10-K) for
the year ended December 31, 2009.
/s/ Ernst
& Young LLP
Nashville,
Tennessee
March 12,
2010